lead position
Sponsored content
Sponsored by
GlobalBlock
Features list
-
Carl Battle has a big job on his hands managing pharmaceutical giant GlaxoSmithKline’s patent team. Michael Loney talks to him and some of his staff about bringing Anoro Ellipta to market, the dreaded patent cliff, combating generic drug companies and navigating developing countries’ IP hostility
-
Michael Williams, Siabon Seet, John Lee, Chris Williams and Lisa Lennon of Gilbert Tobin round up some of the most significant issues in Australian IP matters, including copyright cases, competition actions and deceptive similarity in famous marks
-
Wayne Slater and Daniel Rosenthal of IP Gateway ask whether GUIs and icons are suitable subject matter for protection under Australian designs law, and advise on strategies to deal with them
-
Paul McLachlan and Alex Hutchens of McCullough Robertson warn against an element of Australian competition law that creates particular risk for licensing
-
Malcolm McBratney and Dylan Kerrigan of McCullough Robertson advise on the deceptively straightforward area of franchise arrangements in Australia
-
Andrew F Christie, professor at Melbourne Law School, talks about the major developments in Australia in the past year, his concerns about the new government’s attitude toward innovation and why common preconceptions about the USPTO and EPO may not be quite accurate
Local Insights